ARVN
NASDAQ · Pharmaceuticals
Arvinas Inc
$8.50
+0.20 (+2.41%)
Open$8.37
Previous Close$8.30
Day High$8.55
Day Low$8.30
52W High$14.51
52W Low$6.97
Volume—
Avg Volume921.6K
Market Cap543.36M
P/E Ratio58.43
EPS$0.16
SectorPharmaceuticals
Analyst Ratings
Buy
23 analysts
Price Target
+679.1% upside
Current
$8.50
$8.50
Target
$66.22
$66.22
$44.47
$66.22 avg
$75.30
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 241.89M | 192.03M | 233.97M |
| Net Income | -74,424,550 | -53,177,274 | 39.13M |
| Profit Margin | -30.8% | -29.2% | 16.7% |
| EBITDA | -106,392,624 | -80,242,134 | 67.61M |
| Free Cash Flow | — | — | 28.90M |
| Rev Growth | +26.0% | +26.0% | +1.6% |
| Debt/Equity | 0.00 | 0.00 | 0.23 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,168.88 | +0.34% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.65 | +0.07% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $151.72 | +1.48% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.87 | +0.47% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $73.00 | +2.34% | 11.5 | 30.15B |